Unlicensed and Off-Label Drug Use: Issues and Recommendations

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.4, Iss.6, 2002-01, pp. : 353-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vital unlicensed and off-label drug use thwarts paediatric rights

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Unlicensed and off-label drug use in children: implications for safety

By Choonara Imti

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use in Children: Implications for Safety

By Choonara I. Conroy S.

Drug Safety, Vol. 25, Iss. 1, 2002-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Pediatric Off-Label and Unlicensed Drug Use and Its Implications

Current Clinical Pharmacology, Vol. 12, Iss. 1, 2017-06 ,pp. : 18-25

Bentham Science Publishers

Access to resources Recommend Favorite

Off-label and unlicensed use of antidotes in paediatric patients

By Lifshitz Matityahu Gavrilov Vladimir Gorodischer Rafael

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite